“Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease” has been published in the journal Molecular Neurobiology. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 biomarkers call.
april 3, 2017